Shares of Kodiak Sciences Inc. (KOD) are soaring 5.20% in Monday's trading session, building on the momentum from pre-market activity. The surge comes in response to a significant target price increase from Wall Street analyst firm H.C. Wainwright.

H.C. Wainwright has raised its price target for Kodiak Sciences from $3 to $5, representing a substantial 66.67% increase. This adjustment signals growing confidence in the biotechnology company's potential, despite the firm maintaining a Neutral rating on the stock. The new target price suggests considerable upside potential from KOD's current trading levels.

Investors are interpreting the target price hike as a positive indicator of Kodiak Sciences' future prospects. However, market participants should note that H.C. Wainwright's maintained Neutral stance implies a cautious approach, balancing potential risks and rewards. As the trading session progresses, all eyes will be on KOD to see if it can maintain its early momentum and close out the day with significant gains.